Wednesday, Oct 21, 2026 · SEC filings

What the smart money revealed on Oct 21

Real insider buys17insiders · $5.92M
Real insider sales8insiders · $1.8M
Fund 13Fs filed219quarterly holdings
Activist 13Ds filed115%+ stakes

155 insider filings came in. We hid 46 planned (10b5-1) sellers and 83 people whose filings were routine, like grants and tax withholding.

group

3 insiders at Stone Point Credit Income Fund bought $89.6K of stock

Roles: CCO and Secretary, CFO, President, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Sep 30
$89.6K
trending_up

Bluerock Private Real Estate Fund (BPRE) Director Ramin Kamfar bought $3.35M

271,555 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 19–21
$3.35M
trending_up

FB Financial (FBK) Director Orrin Ingram bought $1.54M

29,081 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 20
$1.54M
trending_up

MSD Investment Officer Brian Williams bought $311K

13,130 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 19
$311K
trending_up

Rapport Therapeutics (RAPP) CFO Troy Ignelzi bought $144K

5,500 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Oct 21
$144K
account_balance

Vest Financial filed its holdings: 414 stocks

Holdings as of Sep 30, 2026. Open the fund to see what it bought and sold.

13F As of Sep 30
$9.52B
account_balance

Canoe Financial filed its holdings: 113 stocks

Holdings as of Sep 30, 2026. Open the fund to see what it bought and sold.

13F As of Sep 30
$8.03B
trending_down

PagSeguro Digital (PAGS) Director Alexandre Magnani sold $710K

Not marked as a planned 10b5-1 sale. Sold 37% of the shares they held directly. Still holds 107,390 shares.

Real sale Form 4 Sold 37% of stake Traded Oct 19–20
$710K
trending_down

Ginkgo Bioworks (DNA) Officer Jason Kelly sold $463K

Not marked as a planned 10b5-1 sale. Sold 26% of the shares they held directly. Still holds 129,065 shares.

Real sale Form 4 Sold 26% of stake Traded Oct 19
$463K
trending_down

Ginkgo Bioworks (DNA) Officer Reshma Shetty sold $418K

Not marked as a planned 10b5-1 sale. Sold 10% of the shares they held directly. Still holds 356,329 shares.

Real sale Form 4 Traded Oct 19
$418K
flag

Saba Capital Management, L.P. filed a 13D on Blackstone Long-Short Credit Income Fund (BGX)

A 13D means a 5%+ owner who may push for changes. An amendment (13D/A) updates an earlier stake.

Activist stake 13D Filed Oct 21
flag

Frazier Life Sciences Holdings II LLC filed a 13D on Frazier Life Sciences Acquisition Corp. II (FLSC)

A 13D means a 5%+ owner who may push for changes. An amendment (13D/A) updates an earlier stake.

Activist stake 13D Filed Oct 21

13F season

Holdings as of Sep 30, 2026 are due Nov 16

7,142 funds have filed so far. 8,899 filed for the quarter before.

Biggest real insider buys this week

Open-market buys by officers and directors, filed in the 7 days up to Oct 21.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist